Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML.
Garland
P
P
Dazzi
F
F
Marin
D
D
D000328:Adult; D001752:Blast Crisis / Q000628:therapy*; D000069439:Dasatinib; D005260:Female; D020544:Graft vs Leukemia Effect / Q000187:drug effects*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib